Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

Non-Clinical Requests

Process Overview

  1. Investigator reviews list of available agents and the Collaborator's studies of interest, if available, on the NCI Formulary website.
  2. Investigator submits Non-Clinical Study Proposal Request to NCI Formulary mailbox (NCIFormulary@mail.nih.gov).
  3. NCI reviews investigator eligibility to participate in the NCI Formulary.
  4. NCI forwards eligible Non-Clinical Proposals to participating Collaborator.
  5. Collaborator has thirty (30) days to review proposed Non-Clinical Study Proposal.
  6. Collaborator approves/disapproves Non-Clinical Study Proposal, response is sent to NCI Formulary mailbox.
  7. NCI informs investigator of approval/disapproval.
  8. Collaborator and Investigator can now discuss details of proposed research plan.
  9. Collaborator sends agreed upon research plan to NCI Formulary mailbox.
  10. NCI sends Investigator a non-negotiable MTA for insertion of research plan and signature. Investigator returns partially-executed MTA to NCI.
  11. NCI fully executes the MTA and returns a copy to the Collaborator and Investigator.
  12. Collaborator ships non-clinical agent supply to Investigator.
  13. Investigator receives agent and begins Non-Clinical research.

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Non-Clinical Requests was originally published by the National Cancer Institute.”

Email